Avenue Biosciences
PrivateLast Round
Seed
Jan 12, 2026
Total Funding Raised
$14.36M
Momentum Score
50 /100
Company Overview
Avenue Biosciences is a transatlantic biotechnology company founded in 2023 that specializes in protein engineering powered by machine learning. The company has developed a platform that combines high-throughput analysis of signal peptides with AI algorithms to optimize protein expression and production. This technology is designed to help biotechnology and pharmaceutical companies accelerate drug development, reduce production costs, and advance the discovery of protein biologics, biosimilars, and mRNA therapies. Headquartered in Palo Alto, California, with laboratory operations in Helsinki, Finland, the company was founded based on research from the University of Helsinki. In October 2024, Avenue Biosciences announced it had raised a $2.5 million seed funding round.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenue Biosciences Comps
Public and private peers based on sector, stage, and business model.
Avenue Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 12, 2026 | ||||
| Seed | Oct 22, 2024 | ||||
| Seed | Jan 16, 2024 |
Key People
Founding team and executive leadership
Avenue Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tesi | Seed |
| University of Helsinki | Seed |
| Balnord | Seed |
| Inventure | Seed |
| Voima Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
$5.7M raised in Seed round.
- May 20, 2025
Veli-Pekka Jaakola appointed as new CTO.
Avenue Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avenue Biosciences's valuation, stock price, and market status.
